Mepolizumab, sold under the brand name Nucala, is a humanized monoclonal antibody used for the treatment of severe eosinophilic asthma, chronic obstructive pulmonary disease (COPD) of an eosinophilic phenotype, eosinophilic granulomatosis with polyangiitis, and hypereosinophilic syndrome.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.